DJ Bristol Myers Squibb Co. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. $(BMY)$ slipped 1.87% to $66.82 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.38% to 7,718.60 and Dow Jones Industrial Average falling 0.51% to 53,414.25.
The stock's fall snapped a four-day winning streak.
Bristol Myers Squibb Co. closed 2.65% below its 52-week high of $68.64, which the company achieved on August 19th.
The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ fell 1.15% to $275.23, Pfizer Inc. $(PFE)$ fell 1.25% to $28.45, and Abbott Laboratories $(ABT)$ fell 0.42% to $108.33.
Trading volume (4.6 M) remained 6.4 million below its 50-day average volume of 11.0 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 4, 2026.